D Dimer Role in Coagulation Activation and Secondary Fibrinolysis
Bruno Pougault, Global Marketing Hemostasis Product Manager at HORIBA, reposted from Horiba on LinkedIn:
”D dimer is an important biomarker of coagulation activation and secondary fibrinolysis that is routinely used to rule out venous thromboembolism (VTE), and to evaluate the risk of VTE recurrence, as well as the optimal duration of anticoagulant therapy.”
Horiba for Healthcare shared on LinkedIn:
”[Register now!] Free Online Workshop
D-Dimer: Diagnostic Challenges and Clinical Relevance
Thursday, October 16, 11–12 AM CEST
Register here.
This online workshop will focus on D dimer, a byproduct of the blood clotting and breakdown process that serves as a marker of ongoing coagulation and fibrinolysis.
The session will explore its clinical use in ruling out deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as the inherent challenges—such as poor specificity, false positives, and difficulties in interpretation, especially in older patients or those with conditions like COVID-19 or cancer.
Participants will learn how to improve diagnostic accuracy and patient management through the use of clinical pretest probability assessments.
The workshop will also discuss the application of age-adjusted D dimer thresholds and the importance of confirmatory imaging in guiding clinical decisions.
Who should attend?
Healthcare professionals involved in D-dimer testing and thromboembolic disease management, such as pathologists, hemostasis lab scientists, acute care nurses, emergency physicians, hospitalists, hematologists, cardiologists, geriatricians, general practitioners, and trainees in related specialties.”
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Apr 14, 2026, 09:32Kalyan Roy: Swirling as a Simple Indicator of Platelet Quality
-
Apr 14, 2026, 09:26Kausik Ray: How Physicians and Patients Perceive Risk in Lipid Modification Therapy
-
Apr 14, 2026, 09:14Hossam Qassem: When To Start Anticoagulation After Cerebral Aneurysm Clipping
-
Apr 14, 2026, 09:09Kevin Land: Near Elimination of Vaso-Occlusive Crises in Sickle Cell Disease
-
Apr 14, 2026, 07:58Anton Ilich։ A New Test for Rapid Detection of Fibrinolysis in Postpartum Hemorrhage
-
Apr 13, 2026, 17:41Peter Zdziarski: Glanzmann’s Research Foundation Listed as GT Patient Organization on NORD
-
Apr 13, 2026, 17:39Nathan Connell: Why Prophylaxis in vWD Has Historically Lagged Behind Established Practice in Hemophilia
-
Apr 13, 2026, 17:38Tareq Abadl: A Blood Transfusion Can Cause a Delayed Platelet Crash
-
Apr 13, 2026, 13:33Tetsumei Urano: Join for the ISTH Educational Programs at APSTH 2026 in Japan